The Lobster Talks Podcast by Lobster Capital

Gabriel Jarrosson
  • 0.0 (0)
  • Investing
  • Updated Weekly

Feast into the Startup Hustle with The Lobster Talks Podcast by Lobster Capital! Craving the real deal on starting and scaling a business? The Lobster Talks Podcast by Lobster Capital serves up raw, unscripted conversations with experienced founders who've been there, done that (and gotten the investor backing!). Join us as we dissect the triumphs and trials of the entrepreneurial journey, peeling back the layers to reveal the nitty-gritty of building a startup from the ground up. Our guests share their unfiltered insights, hard-won lessons, and practical tips to help you navigate the exciting (and sometimes messy) world of startups. Subscribe now and get ready to hear honest, unfiltered stories from seasoned founders, uncover valuable insights and actionable tips for your startup journey, gain inspiration from those who've successfully navigated the fundraising game and join a community of passionate entrepreneurs eager to learn and grow.

  1. 1d ago

    He Sold Firebase to Google. Now He’s Building Tasklet

    How Firebase co-founder Andrew Lee pivoted his way to a $175M valuation and why Big Tech threats shouldn't scare you. Building a massive venture-scale business requires finding acute customer pain, even if it means pivoting away from years of work. Serial founder Andrew Lee shares how he built and sold Firebase to Google, ran into the realities of corporate inertia, and returned to Y Combinator to build Tasklet, an AI command center burning millions on inference.  We cover why investor hype follows extreme growth rates, why incumbents move slower than you think, and how to stay ahead of model providers like OpenAI and Anthropic. What you will learn: How a customer development call transformed a struggling chat app into FirebaseWhy Google's threats to build competing products are usually emptyThe exact metrics Tasklet used to raise at a $175M valuation before Demo DayHow to avoid getting wiped out by frontier models from Anthropic and OpenAIWhy 100% month-over-month growth rate trumps total run rate every single time 📌 Watch now and subscribe for more smart, fast, founder-first interviews. Chapters:  00:00 $30M Inference Teaser 00:14 Meet Andrew Lee 02:25 From Chat to Firebase 05:31 Demo Day Misstep 08:09 Early Checks and Runway 10:45 Why Return to YC 18:34 Tasklet Explained 21:47 Beyond Chat Interfaces 23:05 Future of Software Companies 24:11 YC Roaster Ad Break 24:51 Next Big Question 24:56 Competing With Claude 25:51 Why Tasklet Wins 26:55 Model Marketplace Bet 28:30 Traction Growth Advice 29:18 Painkiller Problems 31:41 Idea Maze Grind 32:46 Timing The Pivot 34:45 Raising Early In YC 38:21 Bigco Threat Reality 39:15 Google Acquisition Lessons 42:24 Carving Niches To Win 45:37 Founder Focus Exception 47:12 Stay Out Of Their Way 48:35 Wrap Up And Links 🎧 Listen on the go:  Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP  Apple: https://apple.co/4cZ8RMm  My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications.  🔗 https://ycroaster.com

  2. Aug 11

    How Panta Is Building a 10x More Efficient Insurance Brokerage

    AI-native startups are no longer selling software to incumbents; they are replacing them completely to capture full margin. Vincent, CEO of Penta, breaks down how he abandoned traditional SaaS to build an AI-native commercial insurance brokerage. We explore why legacy brokers are anti-efficiency, how AI collapses back-office overhead by 90%, and why lean teams of two founders can comfortably scale past $10M ARR. What you will learn: - Why traditional SaaS sales fail in legacy industries and how full-stack replacement wins. - How AI natively shrinks back-office headcount to 1/10th of traditional insurance operations. - The exact unit economics behind 3x productivity gains per headcount. - Why legacy carriers are structurally disincentivized from adopting efficiency tools. - How to leverage AI loops to replace manual human workflows across professional services. 📌 Watch now and subscribe for more smart, fast, founder-first interviews. Chapters: 00:00 AI Replaces Workers 00:29 Meet Penta Founder 01:16 Why Brokers Reject SaaS 02:52 What AI Native Means 05:17 Margins and Distribution 07:27 Legacy Company Playbook 09:48 Self Improving AI Loops 10:50 Next Industries to Disrupt 13:11 Corgi and Market Hype 14:38 How Brokers Work Today 16:43 Scaling Back Office with AI 18:35 Can Carriers Go AI Native 21:02 Regulation Blocks Efficiency 21:39 Insurance Pricing Reality 21:58 Middleman Speed Problem 22:34 AI Fixes Broker Errors 23:31 Hiring and Getting Covered 23:49 Tiny Teams Big Revenue 26:28 Broker Model vs SaaS 27:15 AI Native Unit Economics 29:58 Jobs Displaced by AI 30:53 Humans as Bot Workarounds 32:44 Abundance vs Job Loss 34:10 Hacker House to YC 38:17 Finding Penta Online 38:35 Final Thanks and Wrap 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

  3. Aug 4

    60% of What Chemo Kills Is Healthy. They Have a Fix.

    This YC biotech startup built a genetic kill switch to end cancer. Here is how 3 Oxford PhDs cracked the platform. FinalDose is taking on a $5 trillion market by shifting from traditional search-and-edit gene therapies to search-and-destroy target architectures. By combining CRISPR shape-change mechanics with frontier AI models, they prove how hardware constraints dissolve when software timelines hit deeptech. We sit down with the founders to breakdown their foundational patent, YC batch execution, and the timeline to commercialization. What you will learn: - Why 60 years of targeted protein pharma missed the underlying DNA driver signature - How FinalDose engineered a Cas9 conformational shape change into a cellular kill switch - The exact framework used to validate their platform in just 40 days during YC - How AI models collapse drug discovery costs by 10X and accelerate timelines by 3X - The delivery vectors needed to clear targeted organs like the liver, lung, and skin - How mutation burden per year dictates the biological ceiling for human longevity 📌 Watch now and subscribe for more smart, fast, founder-first interviews. 00:00 Intro 00:18 The $5 Trillion Thesis: Ending Cancer 02:11 Why 60 Years of Pharma Targeted the Wrong Mechanism 04:08 The Eureka Moment: Turning CRISPR into a Kill Switch 06:12 The AI Unlock: Harnessing Conformational Changes 08:04 How YC Forced a Bio Startup onto Software Timelines 10:14 Defending a Foundational Patent Against Big Pharma 13:16 Solving the Specificity and Delivery Bottlenecks 16:11 Can We Delete DNA Damage to Live 300 Years? 19:15 10x Cheaper, 3x Faster: The New Bio Playbook 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

  4. Aug 4

    60% of What Chemo Kills Is Healthy. They Have a Fix.

    This YC biotech startup built a genetic kill switch to end cancer. Here is how 3 Oxford PhDs cracked the platform. FinalDose is taking on a $5 trillion market by shifting from traditional search-and-edit gene therapies to search-and-destroy target architectures. By combining CRISPR shape-change mechanics with frontier AI models, they prove how hardware constraints dissolve when software timelines hit deeptech. We sit down with the founders to breakdown their foundational patent, YC batch execution, and the timeline to commercialization. What you will learn: - Why 60 years of targeted protein pharma missed the underlying DNA driver signature - How FinalDose engineered a Cas9 conformational shape change into a cellular kill switch - The exact framework used to validate their platform in just 40 days during YC - How AI models collapse drug discovery costs by 10X and accelerate timelines by 3X - The delivery vectors needed to clear targeted organs like the liver, lung, and skin - How mutation burden per year dictates the biological ceiling for human longevity 📌 Watch now and subscribe for more smart, fast, founder-first interviews. 00:00 Intro 00:18 The $5 Trillion Thesis: Ending Cancer 02:11 Why 60 Years of Pharma Targeted the Wrong Mechanism 04:08 The Eureka Moment: Turning CRISPR into a Kill Switch 06:12 The AI Unlock: Harnessing Conformational Changes 08:04 How YC Forced a Bio Startup onto Software Timelines 10:14 Defending a Foundational Patent Against Big Pharma 13:16 Solving the Specificity and Delivery Bottlenecks 16:11 Can We Delete DNA Damage to Live 300 Years? 19:15 10x Cheaper, 3x Faster: The New Bio Playbook 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

  5. Jul 28

    Meet YC’s First AI Founder... It’s Already Making Money

    The first AI founder in YC history doesn't sell software. He converts tokens directly into capital at a 3x return. Most founders sell tools. Thomas built an autonomous entity that hires itself out for digital labor, collects payments, and reinvests the profit into compute. We break down the unit economics of token arbitrage, why selling AI software is a strategic error, and how OpenAI and Anthropic are bankrolling YC batch startups with millions in free compute. What you will learn: - What token arbitrage looks like when converting compute into a 3x cash return - Why selling autonomous profits as a SaaS product destroys enterprise value - How the OpenAI $2M uncapped SAFE token deal impacts YC startup dilution - Why domain data moats protect agentic companies from frontier lab cannibalization - The precise balance between RL exploration and exploitation in revenue models - How human founders scale engineering loops while an AI manages ops 📌 Watch now and subscribe for more smart, fast, founder-first interviews. TIMESTAMPS: 00:00 Meet Thomas AI Founder 01:16 Why AI Led Companies 01:37 Virtual Human Money Maker 02:35 How Thomas Earns Today 03:30 Tokens to Profit Loop 05:22 Future Economy And Redistribution 06:20 Why Not Sell Thomas 09:16 Can Labs Copy This 12:06 Why Personify Thomas 15:47 Safety Guardrails And Open Source 19:49 Scaling Tokens And Machines 21:49 Token Budget Strategy 22:30 Scaling ROI Carefully 23:51 Unlimited Tokens Experiment 24:49 Delayed Learning Signals 25:20 Agents and Instant Payments 26:05 No Human Nudges Rule 27:11 Exploration Versus Greed 28:22 Tracking Thomas Publicly 29:18 Fundraising and Margins 32:31 Hiring for Learning Loop 34:22 Money as Value Proxy 37:18 Deploying AGI at Scale 39:08 YC and AI Founders Future 42:00 Investor Reactions and Wrap 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

  6. Jul 21

    The AI Health Assistant He Wished Existed | Juno (YC P26)

    Juno reached 20,000 daily active users with AI health tracking, took $2M from OpenAI, and cracked consumer growth. Here’s how. In this episode, I sit down with Marshall Gold, founder of Juno (YC Spring 26), to unpack how an Oxford genetics researcher turned personal health struggles into one of the standout consumer apps of the batch.  They break down the mechanics of consumer AI virality, why user-generated content ads are hitting a ceiling, and how $2M in OpenAI compute subsidizes their free tier. What you will learn: Why the average chronic illness diagnosis takes 7.6 years and how AI changes the mathHow Juno scaled past 100K signups and 20K DAUs with zero headcount expansionThe exact playbook for transitioning from paid user acquisition to organic loopsWhy UGC marketing fatigue will hit consumer apps over the next 12 monthsHow to structure $2M in compute credits to drive free-tier user referral enginesThe strategic rationale behind local edge models for patient privacy 📌 Watch now and subscribe for more smart, fast, founder-first interviews. TIMESTAMPS: 00:00 Seven Year Diagnosis Problem 00:07 Meet Juno Founder 01:01 Podcast Intro and Stakes 01:55 Marshall Health Journey 02:54 Chronic Illness Social Media 04:06 From Community to Product 05:43 Patient Interviews and YC 06:51 What Juno Actually Does 09:37 Why It Spreads Fast 10:27 Organic Growth Playbook 13:03 UGC Growth Is Fading 15:15 Engineering Virality Features 18:41 OpenAI Token Deal Explained 19:31 Scaling Costs and Free Tier 21:23 When Tokens Run Out 21:58 Edge Models and Privacy 22:50 When Phones Run LLMs 24:18 Scaling Growth Loops 27:54 B2C Versus B2B Virality 33:06 Consumer Growth Plateau 34:34 AI Personalization for Chronic Illness 35:41 OpenAI Health Competition 38:57 Apps Versus Superapps 40:22 Anthropic Case Study 42:31 Where to Find Juno 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP  Apple: https://apple.co/4cZ8RMm  My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications.  🔗 https://ycroaster.com

  7. Jul 14

    This YC Founder Gives Away What Others Sell for Millions

    Most founders think identity verification is just a boring compliance box. Alberto Rosas, CEO of Didit, flipped the script by offering a developer-first freemium model that took the US market by storm. In this episode, we unpack how Didit is using product-led growth to scale an infrastructure play that could outgrow the online payments market. What you will learn: - How Didit cloned the exact developer-first playbook Stripe used to hit a $100B scale - The exact mechanics of cracking PLG in a highly regulated, historically opaque industry - Why the explosion of AI bots will force humans to verify their identity multiple times a day - The structural reason why blockchain is completely inefficient for digital identity protocols - The 20x fundraising arbitrage: A raw look at raising capital in Europe versus Y Combinator Demo Day 📌 Watch now and subscribe for more smart, fast, founder-first interviews. Chapters 00:00 Playing the Big Leagues 00:22 Meet Didit and the Big Bet 01:22 Stripe for Identity 03:17 New Use Cases Beyond Compliance 09:16 AI Fraud and Daily Verification 12:44 Trust Scores and Identity Wallets 16:10 Does Identity Need Blockchain 19:11 Why Join Y Combinator 20:31 Moving to the US for Scale 24:38 YC Roaster Sponsor Break 25:44 YC Network Shortcut 26:19 Credibility And Access 27:40 Inside The YC Batch 29:15 Fundraising 20x Easier 29:41 Why YC Is Unique 31:21 Product Led Growth Basics 33:07 GTM Intuition Over Tests 36:51 Frictionless Transparent Product 39:10 Iterate Fast To Win 43:53 Big Vision And Predictions 45:17 Where To Find Didit 46:11 Final Thanks And Subscribe 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

  8. Jul 7

    Insurance Puts Hospitals On Hold On Purpose. His AI Waits Them Out

    The standard view in enterprise tech is that hospitals are an impossible sell. The sales cycles take years, legacy systems are hopelessly entrenched, and bureaucracy kills early-stage companies. But there is a massive structural loophole. Insurance giants are intentionally creating artificial friction, using mandatory 40 minute phone holds to run out the clock on hospital billing cycles. In this episode, Suhail from LunaBill breaks down how they built a pipeline of enterprise contracts by automating the revenue cycle. We discuss his contrarian approach to pre-seed customer discovery, the real reason why healthcare software giants have an Achilles heel, and how AI is fundamentally unwrapping a multi-trillion-dollar global services economy. What you will learn: - How insurance companies weaponize long wait times to relegate hospital claims into zero percent recovery brackets. - The pre-seed strategy of taking an industry job to map your ICP without burning venture runway. - Why the service industry is ten times larger than software and how AI-native tools scale into it. - How to successfully navigate enterprise vendor consolidation by transforming a point product into a platform. - The 2031 macro prediction for human telephone infrastructure in the medical sector. 📌 Watch now and subscribe for more smart, fast, founder-first interviews. Chapters: 00:00 Dead Revenue Problem 00:05 Meet LunaBill Founder 00:46 Voice AI For Claims 02:09 Insurers Slow Walk 04:18 Outsourcing And AI 04:52 Aging Claims Math 06:46 Origin Story Pivot 09:09 Hospital Buying Psychology 13:28 Jobs Before Startups 17:40 Internship Versus Pivot 19:31 YC Roaster Pitch 20:11 Why Expand Beyond Billing 20:51 Customer Requests Drive Scope 22:02 Hospital Onboarding Reality 23:59 Repositioning as Voice Platform 24:47 Playing to Team Strengths 26:51 AGI Replacement Concerns 28:10 Healthcare Moats Relationships 30:38 Bigco Speed vs Startups 32:20 2031 Prediction AI Calls 33:46 AI Native Revenue Cycle Future 36:06 AI Rewrites Legacy Systems 37:21 Luna Bill Growth Goals 37:53 Where to Find Luna Bill 38:06 Wrap Up and Subscribe 🎧 Listen on the go: Spotify: https://open.spotify.com/show/1u1JyRKH8JYFjhBkvTUOAP Apple: https://apple.co/4cZ8RMm My other YouTube Channel: https://www.youtube.com/@lobstercap This Lobster Talks episode is brought to you by YC Roaster, a free tool helping founders improve their YC applications. 🔗 https://ycroaster.com

See All (111)

Trailer

About

Feast into the Startup Hustle with The Lobster Talks Podcast by Lobster Capital! Craving the real deal on starting and scaling a business? The Lobster Talks Podcast by Lobster Capital serves up raw, unscripted conversations with experienced founders who've been there, done that (and gotten the investor backing!). Join us as we dissect the triumphs and trials of the entrepreneurial journey, peeling back the layers to reveal the nitty-gritty of building a startup from the ground up. Our guests share their unfiltered insights, hard-won lessons, and practical tips to help you navigate the exciting (and sometimes messy) world of startups. Subscribe now and get ready to hear honest, unfiltered stories from seasoned founders, uncover valuable insights and actionable tips for your startup journey, gain inspiration from those who've successfully navigated the fundraising game and join a community of passionate entrepreneurs eager to learn and grow.

Information